A new survey by URCH Publishing, an independent business information firm, highlights the increasing trend towards direct-to-pharmacy medicine supply in Europe. Principal author Faiz Kermani explains that "the adoption of a direct-to-pharmacy model by some of the industry's most powerful players...signifies a new trend that could spread across Europe."
Dr Kermani added that, with major manufacturers driving the changes, the near-term prospects for pharmacists appear bleak, and he predicted the emergence of a new class of super-distributors with links to selected wholesalers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze